Viewing Study NCT03706703


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-01-06 @ 7:02 PM
Study NCT ID: NCT03706703
Status: UNKNOWN
Last Update Posted: 2018-10-17
First Post: 2018-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module